Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-ART-45173
Anesth Analg 2012 Jul 01;1151:70-2. doi: 10.1213/ANE.0b013e318254273e.
Show Gene links Show Anatomy links

Carboetomidate inhibits alpha4/beta2 neuronal nicotinic acetylcholine receptors at concentrations affecting animals.

Pierce DW , Pejo E , Raines DE , Forman SA .


???displayArticle.abstract???
Carboetomidate is an etomidate derivative that produces hypnosis without inhibiting adrenal corticosteroid synthesis. Similar to etomidate, carboetomidate modulates γ-aminobutyric acid type A receptors, but its effects on other ion channel targets of general anesthetics are unknown. We compared etomidate and carboetomidate effects on human N-methyl-d-aspartate receptors or neuronal nicotinic acetylcholine receptors (nnAChRs) expressed in Xenopus oocytes, using 2-microelectrode voltage clamp electrophysiology. Etomidate did not affect either type of receptor at clinically relevant concentrations, whereas carboetomidate concentrations near 50% effective concentration for anesthesia significantly inhibited nnAChRs. Compared with etomidate, carboetomidate's higher hydrophobicity is associated with greater inhibition of nnAChRs.

???displayArticle.pubmedLink??? 22543065
???displayArticle.pmcLink??? PMC3381859
???displayArticle.link??? Anesth Analg
???displayArticle.grants??? [+]


References [+] :
Belelli, The in vitro and in vivo enantioselectivity of etomidate implicates the GABAA receptor in general anaesthesia. 2003, Pubmed, Xenbase